SYS6040

· CSPC Megalith Biopharmaceutical Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYS6040, covering 2025-05-14 to 2025-05-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors [Phase 1]